Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo

被引:45
作者
Jaffee, BD [1 ]
Manos, EJ [1 ]
Collins, RJ [1 ]
Czerniak, PM [1 ]
Favata, MF [1 ]
Magolda, RL [1 ]
Scherle, PA [1 ]
Trzaskos, JM [1 ]
机构
[1] Dupont Merck Pharmaceut Co, Inflammatory Dis Res, Wilmington, DE 19880 USA
关键词
D O I
10.1006/bbrc.2000.2184
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The MAP kinase pathway has been well-characterized as a cascade of sequential protein phosphorylation events leading to the upregulation of a variety of genes in response to growth factors and mitogens, We are interested in the role of these kinases in inflammation and have thus examined their activity in vivo using TPA-induced ear edema in the mouse as a model of inflammation, We show that the activities of both ERK-1 and ERK-2 are upregulated in this model in response to TPA, Increased levels of ERK phosphorylation are measurable as early as 15 min poststimulation and reach a level 8-fold over controls at 4 h, In contrast, minimal activation of JNK or p38 is observed. Topical treatment of ears with the MEK inhibitor, U0126, prevents ERK phosphorylation and ear swelling in a dose-dependent manner in this model. These results suggest that the MEK/ERK pathway is important during an inflammatory response in vivo. (C) 2000 Academic Press.
引用
收藏
页码:647 / 651
页数:5
相关论文
共 28 条
[1]  
ALLISON AC, 1993, ANN NY ACAD SCI, V696, P149
[2]  
Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453
[3]  
BIRCHALL AM, 1994, J PHARMACOL EXP THER, V268, P922
[4]   SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233
[5]   Identification of a novel inhibitor of mitogen-activated protein kinase kinase [J].
Favata, MF ;
Horiuchi, KY ;
Manos, EJ ;
Daulerio, AJ ;
Stradley, DA ;
Feeser, WS ;
Van Dyk, DE ;
Pitts, WJ ;
Earl, RA ;
Hobbs, F ;
Copeland, RA ;
Magolda, RL ;
Scherle, PA ;
Trzaskos, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :18623-18632
[6]  
Foey AD, 1998, J IMMUNOL, V160, P920
[7]   Transcriptional regulation in the immune system: all roads lead to AP-1 [J].
Foletta, VC ;
Segal, DH ;
Cohen, DR .
JOURNAL OF LEUKOCYTE BIOLOGY, 1998, 63 (02) :139-152
[8]   Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A(2) [J].
Glaser, KB ;
Sung, MLA ;
Hartman, DA ;
Lock, YW ;
Bauer, J ;
Walter, T ;
Carlson, RP .
SKIN PHARMACOLOGY, 1995, 8 (06) :300-308
[9]   Cytosolic phospholipase A(2) and its mode of activation in human neutrophils by opsonized zymosan - Correlation between 42/44 kDa mitogen-activated protein kinase, cytosolic phospholipase A(2) and NADPH oxidase [J].
Hazan, I ;
Dana, R ;
Granot, Y ;
Levy, R .
BIOCHEMICAL JOURNAL, 1997, 326 :867-876
[10]   Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide - Mediation through both mitogen-activated protein kinase and NF-kappa B signaling pathways in macrophages [J].
Hwang, D ;
Jang, BC ;
Yu, G ;
Boudreau, M .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (01) :87-96